Core Scientific, Inc. provides infrastructure for high-density colocation services and digital asset mining in the United States. It operates through three segments: Colocation, Digital Asset Self-Mining, and Digital Asset Hosted Mining.
Show moreShow less
The company offers space, power, cooling, facilities operations, security, and other services to third-party customers to support workloads for machine learning and artificial intelligence; deployment, monitoring, troubleshooting, optimization, and maintenance of its customers' digital asset mining equipment; and electrical power, repair, and other infrastructure services for its customers to operate, maintain, and mine digital assets.
It is also involved in the deployment and operation of its fleet of miners within its digital infrastructure as part of a pool of users that process transactions conducted on one or more blockchain networks to receive digital assets in the form of bitcoin.
It also deploys and operates its fleet of miners within its digital infrastructure as part of a pool of users that process transactions conducted on one or more blockchain networks; and provides hosting services for digital asset mining customers, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.
Core Scientific, Inc. was founded in 2017 and is headquartered in Dover, Delaware.
Quality Score breakdown
Overall quality23/100
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Profitability1
How much profit the company makes from its sales and capital
Quality Growth40
Are margins and returns getting better?
Cashflow33
Do the profits arrive as real cash?
Financial strength15
Debt, balance sheet and risk of trouble
Investment0
Does it invest with discipline instead of growing at any price?
Low Volatility0
How calm the share price moves, does not count
Price momentum3
Price momentum of the last 3 to 12 months, does not count
In the last 6 months, 2 officers or directors bought shares worth $342,290, most recently on Sep 15, 2026. Over the same period, one person sold shares worth $5.4M. Buying cluster
SaleTodd M DucheneOfficer32× since Apr 1, 2026: 320,000 shares, avg. $20.32$6.5MNov 2, 202610b5-1 plan
BuyEric Stanton WeissDirector3× since Mar 9, 2026: 20,000 shares, avg. $16.70$334,020Sep 15, 2026
BuyElizabeth CrainDirector6,000 shares at $18.33$109,980Aug 20, 2026
Plus 13 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.32/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−37.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−20.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+39.5%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+32.3%
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−10.5% (2020) → −70.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Compare Core Scientific, Inc. Common Stock with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Software - Infrastructure · 345 stocks
Beats the industry median on 2/6 measures
Overall it trails its industry peers.
Valuation
Quality Score23 · Bottom 25%
Profitability
Return on equity (12 months)Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets−12.3% · Bottom 25%
Net margin (12 months)−90.5% · Bottom 25%
Operating margin (12 months)6.9% · Above median
Growth and dividend
Revenue growth (quarter YoY)108.8% · Top 25%
Balance sheet
Debt / equityNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Valuation Multiplesvs Software - Infrastructure median · lower = cheaper
P/BNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (12 months)8.69× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 25
FUTURE (revenue growth)100· sector 60
PAST (return on equity)0· sector 23
HEALTH (low debt)0· sector 98
DIVIDEND (yield)0· sector 31
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
Core Scientific, Inc. has a Quality Score of 23/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Core Scientific, Inc. (CORZ)?
Core Scientific, Inc. reported trailing-twelve-month revenue of about $440M (latest available figure, as of Jun 23, 2026).
How solid is the balance sheet of Core Scientific, Inc. (CORZ)?
Balance-sheet figures for Core Scientific, Inc. (as of Jun 23, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 23/100, which measures business quality independently of the share price.
Which stocks are comparable to Core Scientific, Inc. Common Stock?
From the same area (Technology) we also value Microsoft Corporation, Oracle Corporation, Palantir Technologies Inc, Palo Alto Networks, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
What is the share price of Core Scientific, Inc. (CORZ)?
The closing price on Nov 6, 2026 was $11.76. We carry closing prices from our data provider, not a live tick.
Key figures of Core Scientific, Inc.
How large is the market capitalisation of Core Scientific, Inc. (CORZ)?
The market capitalisation of Core Scientific, Inc. is $3.8B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Core Scientific, Inc. (CORZ)?
The price-to-sales ratio of Core Scientific, Inc. is 9.31 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Core Scientific, Inc. (CORZ)?
Earnings per share at Core Scientific, Inc. are $−4.25. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Core Scientific, Inc. (CORZ)?
The net margin of Core Scientific, Inc. is −90.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Core Scientific, Inc. (CORZ)?
On an EBIT basis the return on assets of Core Scientific, Inc. is −6.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Core Scientific, Inc. (CORZ)?
The operating margin of Core Scientific, Inc. is 6.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Core Scientific, Inc. (CORZ)?
Revenue at Core Scientific, Inc. is growing +109% versus a year earlier (3y avg −20.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Core Scientific, Inc. (CORZ)?
Earnings per share at Core Scientific, Inc. are growing +61.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Core Scientific, Inc. (CORZ) generate?
The free cash flow of Core Scientific, Inc. is −$451M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Core Scientific, Inc. (CORZ) carry?
The net debt of Core Scientific, Inc. is $749M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Core Scientific, Inc. Common Stock in the live analysis
One click puts Core Scientific, Inc. Common Stock on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Jun 23, 2026